Kairos Pharma, Ltd. (KAPA) Ownership - Who Owns Kairos Pharma, Ltd.?
Kairos Pharma, Ltd. (KAPA) Ownership Overview
- 32.08% Insiders
- 1.26% Mutual Funds
- 0.29% ETFs
- 66.37% Public Companies and Individual Investors
The ownership structure of Kairos Pharma, Ltd. (KAPA) stock is a mix of institutional, retail, and individual investors. Approximately 1.55% of the company’s stock is owned by Institutional Investors, 32.08% is owned by Insiders, and 66.37% is owned by Public Companies and Individual Investors.
The ownership structure of Kairos Pharma, Ltd. (KAPA) stock is a mix of institutional, retail, and individual investors. Approximately 1.55% of the company’s stock is owned by Institutional Investors, 32.08% is owned by Insiders, and 66.37% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Neil Bhowmick | 1,311,739 | Insider | 38.75% | 695,222 |
| Murali Ramachandran | 299,529 | Insider | 8.85% | 158,750 |
| Doug Samuelson | 293,039 | Insider | 8.66% | 155,311 |
| Hyun W. Bae | 73,370 | Insider | 2.17% | 38,886 |
| Rahul Singhvi | 49,204 | Insider | 1.45% | 26,078 |
| Hansoo Michael Keyoung | 29,084 | Insider | 0.86% | 15,415 |
| Vanguard | 9,707 | Institution | 0.29% | 5,145 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXF ETF | 9,707 | Institution | 0.29% | 15,919 |
FAQ
Who Owns Kairos Pharma, Ltd. (KAPA)?
According to the latest TipRanks data, approximately 1.55% of the company's stock is held by institutional investors, 32.08% is held by insiders, and 66.37% is held by public companies and individual investors.
What percentage of Kairos Pharma, Ltd. (KAPA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.55% of Kairos Pharma, Ltd. (KAPA) stock is held by institutional investors: 1.26% by mutual funds and 0.29% by ETFs.
What percentage of Kairos Pharma, Ltd. (KAPA) stock is held by retail investors?
According to the latest TipRanks data, approximately 66.37% of Kairos Pharma, Ltd. (KAPA) stock is held by public companies and individual investors.
Who owns the most shares of Kairos Pharma, Ltd. (KAPA)?
Neil Bhowmick owns the most shares of Kairos Pharma, Ltd. (KAPA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
